Chubb Unit Prices $1 Billion Senior Notes Offering-March 2024-www.financetom.com

Chubb Unit Prices $1 Billion Senior Notes Offering

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Chubb Unit Prices $1 Billion Senior Notes Offering

Mar 5, 2024 2:37 AM

05:19 AM EST, 03/05/2024 (MT Newswires) -- Chubb ( CB ) said Tuesday that its Chubb INA Holdings unit has priced a public offering of $1 billion in 5% senior notes due 2034.

The notes are guaranteed by the parent company and Chubb ( CB ) said proceeds will be used for general working capital, including the repayment upon maturity of its $700 million 3.35% senior notes due May 15, 2024.

Previous page： Kemper Insider Bought Shares Worth $920,500, According to a Recent SEC Filing Next page： MacroGenics Q3 revenue declines, secures $75 mln in partnerships

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Kemper Insider Bought Shares Worth $920,500, According to a Recent SEC Filing

Nov 12, 2025

04:13 PM EST, 11/12/2025 (MT Newswires) -- Stuart B. Parker, Director, on November 10, 2025, executed a purchase for 25,000 shares in Kemper (KMPR) for $920,500. Following the Form 4 filing with the SEC, Parker has control over a total of 48,152 common shares of the company, with 48,152 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/860748/000183151125000004/xslF345X05/wk-form4_1762981277.xml ...

MacroGenics Q3 revenue declines, secures $75 mln in partnerships

Nov 12, 2025

Overview * MacroGenics ( MGNX ) Q3 revenue declines 34.2% yr/yr * Company secures $75 mln in partnering proceeds from Sanofi and Gilead * MacroGenics ( MGNX ) ends lorigerlimab prostate cancer development, continues ovarian cancer focus Outlook * MacroGenics ( MGNX ) extends cash runway guidance into late 2027 * Company continues development of lorigerlimab in ovarian cancer *...

Largo Q3 net loss widens

Nov 12, 2025

Overview * Largo Q3 2025 revenue rises to $33.3 mln from $29.9 mln in Q3 2024 * Company reports Q3 net loss of $36.6 mln, impacted by deferred tax asset derecognition * Adjusted cash operating costs per lb sold improved by 2% in Q3 2025 Outlook * Largo did not provide specific guidance for future quarters or the full year...

CuriosityStream Q3 revenue beats estimates on subscription growth

Nov 12, 2025

Overview * CuriosityStream ( CURI ) Q3 revenue grows 46% yr/yr, beating analyst expectations * Company reports positive adjusted EBITDA of $3 mln, improved from a loss last year * CuriosityStream ( CURI ) declares $0.08 per share dividend, payable December 19, 2025 Outlook * Company expects Q4 revenue between $18 mln and $20 mln, a 27%-42% growth * CuriosityStream...